Trypanosomiasis, African |
|
|
Clinical Trial: Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to evaluate, treat and follow patients with parasitic infections.
People with a known or suspected parasitic infection who are at least 1 year old may be enrolled. This study does not involve any experimental treatments.
Participants will have a physical examination and laboratory tests on blood, stool, or urine. Blood samples may be collected at regular intervals, but no more than 450 ml (15 ounces) of blood will be drawn from adults, and no more than 7 ml (1-1/2 teaspoons) per kg (2.2 pounds) of body weight from children, in any 6-week period. Other tests may include x-rays, electrocardiogram (EKG), or tissue biopsy (surgical removal of a small tissue sample), depending on the individual's condition.
Patients may be offered treatment or may be referred to another study that is more appropriate for the problem. Any treatment provided in this study will be according to standard medical practice for the patient's specific medical problem. Patients' responses to treatment will be evaluated at regularly scheduled clinic visits. The length of time between visits and the total duration of the study for a given individual will be determined by the study doctor, based on that person's medical condition.
| Condition |
|---|
| Chagas Disease Malaria Parasitic Disease Trypanosomiasis |
MedlinePlus related topics: Chagas Disease; Malaria; Parasitic Diseases; Pfiesteria Infections
Study Type: Observational
Study Design: Natural History
Official Title: Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection
Expected Total Enrollment: 300
Study start: March 19, 1997
This study is designed as a prospective study to evaluate and treat patients with parasitic infection. Up to 300 patients with known or suspected parasitic infection will be enrolled and will be evaluated for the presence of a parasitic infection. Minimal studies scheduled for each visit will include a medical history, physical examination, routine laboratory tests and specialized diagnostic procedures for possible parasitic infections. Treatment plans will be individualized for each patient's particular condition, and the number and length of additional visits and diagnostic evaluations will vary accordingly. Specific treatment regimens will be in accordance with standard medical practice.
Eligibility
Genders Eligible for Study: Both
Criteria
Age1 or over.
Ability to give written informed consent (for adults) and parental consent (for those under 18).
Clinical evidence suggestive of a parasitic infection.
Location and Contact Information
Maryland
National Institute of Allergy and Infectious Diseases (NIAID), 9000 Rockville Pike, Bethesda, Maryland, 20892, United States; Recruiting
TTY 1-866-411-1010
More Information
Detailed Web Page
Publications
Aggarwal A, Nash TE. Antigenic variation of Giardia lamblia in vivo. Infect Immun. 1988 Jun;56(6):1420-3.
Gallin JI, Farber JM, Holland SM, Nutman TB. Interferon-gamma in the management of infectious diseases. Ann Intern Med. 1995 Aug 1;123(3):216-24. Review.
Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis. 1994 May;169(5):1076-9.
Record last reviewed: February 8, 2005
Last Updated: March 29, 2005
Record first received: November 3, 1999
ClinicalTrials.gov Identifier: NCT00001645
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- African Trypanosomiasis (Centers for Disease Control and Prevention)

Not Signed In -

